Chemotherapy & Targeted Therapies Flash Cards
Updated by the Chemotherapy & Targeted Therapy Subcommittee (2022-2023 term) the Chemotherapy & Targeted Therapy flash cards PDF resource highlights therapies and offer a “refresher” on dosing, side effects, contraindications, and more. Please also access the new and expanded Antineoplastic Therapy for Gynecologic Malignancies – 4th edition e-book, which is available on SGO ConnectEd by search.
Included in this resource are individual PDFs on the following:
- Adavosertib
- Anastrozole
- Atezolizumab
- Avelumab
- Bastilimab
- Bevacizumab
- Cediranib
- Cemiplimab
- Dostarlimab
- Durvalumab
- Everolimus
- Erlotinib
- Exemestane
- Fulvestrant
- Iplimumab
- Ixbepilone
- Letrozole
- Levonorgestrel
- Medroxyprogesterone acetate
- Megestrol acetate
- Mirvetuximab
- Metformin
- Nivolumab
- Oxaliplatin
- Oxaliplatin Capecitabine
- Palbociclib
- Pazopanib
- Pembrolizumab
- Pemrolizumab Lenvatinib
- Ribociclib
- Tamoxifen
- Temsirolimus
- Trabectedin
- Trametinib
- Trastuzumab
- Trastuzumab Deruxtecan (Enhertu®)
- Tisotumab
- Zalifrelimab
Keywords: Chemotherapy, targeted therapy, clinical practice, immunotherapy, targeted, flash cards
Target Audience
Physicians, APPs, NPs, RNs